Fvefrenz Pharmaceutical Private Limited
About Fvefrenz Pharmaceutical Private Limited
Data last updated:
Fvefrenz Pharmaceutical Private Limited is a private limited company based in Udaipur, Rajasthan, India. It operates in the health and beauty retail and distribution segment of the consumer goods sector. It was incorporated on 11 March 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24232RJ2016PTC049568. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Subhash George and Vijay Singh Sengar.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at 74 Ambedkar Colony 'B' Block Sec – 14 Near Abhisek Complex, Udaipur, Rajasthan, India – 313001.
As per the financials filed for FY 2019, the company reported a revenue of ₹9.6 Lakh, a growth of 30% compared to the previous year. For the same year it recorded a net loss of ₹4.66 Lakh (net margin -48.6%) and EBITDA of -₹4.53 Lakh (EBITDA margin -47.2%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Fvefrenz Pharmaceutical Private Limited's registered office is in Udaipur, Rajasthan. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address74 Ambedkar Colony 'B' Block Sec – 14 Near Abhisek Complex, Udaipur, Rajasthan, India – 313001
- IndustryConsumer Goods, Health & Beauty Retail & Distribution
To see the full contact details of Fvefrenz Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Fvefrenz Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Fvefrenz Pharmaceutical Private Limited, buy the company report.
Financials of Fvefrenz Pharmaceutical Private Limited
FY 2019 filings availableFvefrenz Pharmaceutical Private Limited reported revenue of ₹9.6 Lakh (up 30% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue rose 30% in the latest year. EBITDA fell 700% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ₹9.6 Lakh | |||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹4.53 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹4.66 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -47.2% | |||
| Net Profit Margin | -48.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Fvefrenz Pharmaceutical Private Limited, buy the company report.
Board of directors of Fvefrenz Pharmaceutical Private Limited
Fvefrenz Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Subhash George Also directs: Horeb Lifesciences (OPC) Private Limited | Director | 11 Mar 2016 | 10 Years 7 Months | Current |
| Vijay Singh Sengar | Director | 13 May 2019 | 7 Years 5 Months | Current |
Peer comparison
Fvefrenz Pharmaceutical Private Limited is compared with the 5 companies closest to it by revenue in the Consumer Products industry (Health and Beauty Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Salutary Pharmaceuticals Private Limited | ₹9.67 Lakh (FY 2025) | -12.0% | Lucknow, Uttar Pradesh, India | |||
| Shamroha Lifesciences Private Limited | ₹9.66 Lakh (FY 2024) | -1.0% | New Delhi, Delhi, India | |||
| As Organised Business Solutions Private Limited | ₹9.62 Lakh (FY 2019) | Delhi, India | ||||
| Fvefrenz Pharmaceutical Private Limitedthis company | ₹9.6 Lakh (FY 2019) | -₹4.66 Lakh | -48.6% | 30.0% | Udaipur, Rajasthan, India | |
| Switch 2 Nature Incense Limited | ₹9.59 Lakh (FY 2024) | 4148.0% | Delhi, India | |||
| Amista Labs Private Limited | ₹9.56 Lakh (FY 2024) | -82.0% | Chandigarh, India |
To see the full peer comparison of Fvefrenz Pharmaceutical Private Limited, buy the company report.
Auditor
Fvefrenz Pharmaceutical Private Limited is audited by MANGAL JHANWAR & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MANGAL JHANWAR & ASSOCIATES | FY 2019 | 015233C |
Shareholding
The shareholding of Fvefrenz Pharmaceutical Private Limited is on record for 4 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Fvefrenz Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Fvefrenz Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Fvefrenz Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Fvefrenz Pharmaceutical has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Fvefrenz Pharmaceutical Private Limited, buy the company report.
Recent activity
Fvefrenz Pharmaceutical Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Dheerendra Bhardwaj ceased to be Director on 13 May 2019.
Frequently asked questions
Fvefrenz Pharmaceutical is an active private limited company based in Udaipur, Rajasthan, India. The company works in health and beauty retail and distribution, within the consumer goods industry. It was incorporated on 11 March 2016 (10+ years old) and is registered under CIN U24232RJ2016PTC049568.
Fvefrenz Pharmaceutical has 2 current directors:
- Subhash George - Director
- Vijay Singh Sengar - Director
The latest financial statements of Fvefrenz Pharmaceutical on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from FY 2016 are in the company report.
No. Fvefrenz Pharmaceutical has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Fvefrenz Pharmaceutical is U24232RJ2016PTC049568. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Fvefrenz Pharmaceutical was incorporated on 11 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Fvefrenz Pharmaceutical by revenue are Salutary Pharmaceuticals Private Limited, Shamroha Lifesciences Private Limited, As Organised Business Solutions Private Limited, Switch 2 Nature Incense Limited, Amista Labs Private Limited, all in the Consumer Products industry (Health and Beauty Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Dheerendra Bhardwaj ceased to be Director on 13 May 2019. Vijay Singh Sengar was appointed as Director on 13 May 2019. Subhash George was appointed as Director on 11 Mar 2016.
The registered office of Fvefrenz Pharmaceutical is at 74 Ambedkar Colony B Block Sec – 14 Near Abhisek Complex, Udaipur, Rajasthan, India – 313001.
Fvefrenz Pharmaceutical operates in the consumer goods industry, in the health and beauty retail and distribution segment.
The compliance status of Fvefrenz Pharmaceutical is compliant as of 29 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
